Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 213

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 213
---
 Board Member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). Olivier is a graduate of HEC ( École des Hautes Études Commerciales ) and of the Institut d’Études Politiques in Paris. Olivier Charmeil is a citizen of France. Audrey Duval Executive Vice President, Corporate Affairs Date of birth: December 6, 1977. Audrey Duval joined Sanofi in September 2022, as President, Sanofi France. Audrey began her career in public hospitals in Paris and went on to work as a Researcher at the Pasteur Research Center of Hong Kong University and then as a Scientific Expert at Salusmed, based in Hong Kong. She later returned to France to join Pfizer, working in medical affairs in the areas of Endocrinology, Transplant and Rheumatology. and continues to retain that role, supporting and coordinating Sanofi’s representation to its various external stakeholders in France. Prior to joining Sanofi, Audrey worked for Novartis, where she served as Business Franchise Head for Ophthalmology and then Country President for the company’s operations in Ireland. Audrey holds a Medical Doctorate from the Paris Faculty of Medicine Cochin, and a Bachelor of Science in Medical Biology. Audrey Duval is a citizen of France. Brian Foard Executive Vice President, Specialty Care Date of birth: December 20, 1973. As head of our Specialty Care GBU, Brian oversees an extensive portfolio of medicines in immunology, neuro-inflammation, rare diseases, and oncology. Brian and his colleagues are responsible for launching treatments in those fields, and for implementing the strategy to bring Sanofi’s scientific breakthroughs to patients. Brian joined Sanofi in March 2017 as the Global Head of Dermatology and Respiratory, and held roles of increasing responsibility, including as Head of Global Immunology for Sanofi and then as US Country Lead and Head of Specialty Care for North America. He has over 20 years’ experience in the specialist biopharma industry, and began his career with Galderma where he spent more than 10 years in the US before relocating to Paris to lead global marketing and launch readiness. During his time at Galderma, Brian also served in roles including General Manager for Australia & New Zealand and Vice President & General Manager of the global prescription business unit. Brian received a degree in business from East Carolina University and has completed an executive education course at Wharton. Brian Foard is a citizen of the United States.